Company intelligence / Profile preview
Advanced Microbubbles Inc
Newark, California, United Statesadvancedmicrobubbles.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Advanced Microbubbles has demonstrated in preclinical studies that its size-isolated, ultrasound-triggered microbubble platform can safely and transiently open the blood-brain barrier for drug delivery, improve immunotherapy efficacy in pancreatic cancer models, and enable treatment of high-risk neuroblastoma with reduced chemotoxic side effects. No clinical trial results have been reported as of May 2025.
- Therapeutic areas
- Oncology
- Modalities
- Drug delivery systems (ultrasound-triggered microbubbles)Gene therapy delivery platformsImmunotherapy enhancement (via drug delivery)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
IndieBio/SOSV accelerator program partnership
Beyond the preview
Go deeper on Advanced Microbubbles Inc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advanced Microbubbles Inc.